Tygacil — CareFirst (Caremark)
Complicated intra-abdominal infections caused by susceptible isolates of Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus group (S. anginosus, S. intermedius, S. constellatus), Bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Clostridium perfringens, and Peptostreptococcus micros
Initial criteria
- Patient age ≥ 18 years
- Used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria
- Appropriate cultures obtained before therapy to identify causative organism and confirm susceptibility
- Not indicated for diabetic foot infections or hospital-acquired or ventilator-associated pneumonia
- May be initiated empirically prior to culture results if serious infection suspected